Literature DB >> 21594784

Approaches to study CFTR pre-mRNA splicing defects.

Elisa Goina1, Eugenio Fernandez-Alanis, Franco Pagani.   

Abstract

In cystic fibrosis, genomic variants can result in defective processing of the CFTR precursor mRNA. Due to the complexity of the splicing process, the evaluation of their pathological effect is an important aspect both in the diagnostic field and in the study of basic regulatory mechanism. Efficient and correct splicing of CFTR relies on a complex process that includes recognition within the nascent transcripts of a series of different splicing regulatory elements that frequently overlap with the coding sequences. Identification of these elements is essential to determine the pathological impact of splicing-affecting genomic variants. In this chapter, to evaluate the effect of CFTR DNA variations on the pre-mRNA splicing process, different tools based on hybrid minigenes will be described.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21594784     DOI: 10.1007/978-1-61779-117-8_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Experimental assessment of splicing variants using expression minigenes and comparison with in silico predictions.

Authors:  Neeraj Sharma; Patrick R Sosnay; Anabela S Ramalho; Christopher Douville; Arianna Franca; Laura B Gottschalk; Jeenah Park; Melissa Lee; Briana Vecchio-Pagan; Karen S Raraigh; Margarida D Amaral; Rachel Karchin; Garry R Cutting
Journal:  Hum Mutat       Date:  2014-09-10       Impact factor: 4.878

Review 2.  Innovative Therapies for Cystic Fibrosis: The Road from Treatment to Cure.

Authors:  Giulio Cabrini
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

3.  A deep learning approach to identify gene targets of a therapeutic for human splicing disorders.

Authors:  Dadi Gao; Elisabetta Morini; Monica Salani; Aram J Krauson; Anil Chekuri; Neeraj Sharma; Ashok Ragavendran; Serkan Erdin; Emily M Logan; Wencheng Li; Amal Dakka; Jana Narasimhan; Xin Zhao; Nikolai Naryshkin; Christopher R Trotta; Kerstin A Effenberger; Matthew G Woll; Vijayalakshmi Gabbeta; Gary Karp; Yong Yu; Graham Johnson; William D Paquette; Garry R Cutting; Michael E Talkowski; Susan A Slaugenhaupt
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.